✦ LIBER ✦

WS1.3 Enhanced correction of F508del CFTR using drug-like small molecules in combination with correctors and potentiators

✍ Scribed by Miller, J.P.; Drew, L.; Green, O.; Villella, A.; Bastos, C.; Munoz, B.; Cullen, M.D.; Hauck, S.; Wachi, S.; Giuliano, K.; Longo, K.A.; Roskelley, E.; Dobbs, W.; Garza, D.; Haeberlein, M.; Weiner, D.; Bridges, R.J.; Thakerar, A.; Hutt, D.M.; Balch, W.E.; Tait, B.D.

Book ID: 124112746
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 70 KB
Volume: 13
Category: Article
ISSN: 1569-1993
DOI: 10.1016/S1569-1993(14)60006-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WS7.3 VX-661, an investigational CFTR co

WS7.3 VX-661, an investigational CFTR corrector, in combination with ivacaftor, a CFTR potentiator, in patients with CF and homozygous for the F508Del-CFTR mutation: Interim analysis

✍ Donaldson, S.; Pilewski, J.; Griese, M.; Dong, Q.; Lee, P.-S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 72 KB

WS4.3 Rescue of F508del-CFTR without the

WS4.3 Rescue of F508del-CFTR without the regulatory insertion (ΔRI) and regulatory extension (ΔRE) in combination with genetic revertants and small molecules

✍ Uliyakina, I.; da Paula, A.C.; Sousa, M.; Felicio, V.; Afonso, S.; Awatade, N.T. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB